iFluor® 680 Anti-human CD38 Antibody *HIT2*
HIT2 is an anti-human monoclonal antibody that targets the CD38 antigen. CD38 (alternatively called T10) is a 45 kD transmembrane protein that is found on the surface of cells such as NK cells, macrophages and stem cells. CD38 is a component of vital cellular pathways, namely, the apoptotic signaling pathway and B cell receptor signaling pathway. In addition, in certain organisms, it represses apoptotic process, is a positive regulator of cell growth and is an enhancer of vasoconstriction. From a research standpoint, it is of biological interest due to its association with critical macromolecules/ligands like HLA Class II, CD31, CD16 and Hyaluronic acid. CD38 is a fairly uncommon antibody target, with a little more than 10000 publications in the last decade. Even still, CD38 has been widely used in immunology research, commonly serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to iFluor® 680 (ex/em = 684/701 nm).
Spectrum
Conjugation
We provide custom conjugation services for this antibody (eg. labeling of cd38 antibody with HRP). A list of available labels can be found in the table below:
For additional information about custom conjugations, please consult our services page here.
AF | AF350, AF488, AF555, AF594, AF647, AF680, AF700, AF750 |
Proteins | HRP, Alkaline Phosphatase, Streptavidin |
Tandems | APC, APC/Cy7, APC/AF750, APC/iFluor™ 700, APC/iFluor™ 750, PE, PE/Cy5, PE/Cy7, PE/AF610, PE/AF700, PE/iFluor™ 594, PE/iFluor™ 647, PE/iFluor™ 700, PE/iFluor™ 750, PE/Texas Red®, PerCP, PerCP/Cy5.5 |
Small Molecules | Biotin |
Traditional Dyes | FITC (fluorescein), TRITC, PacBlue, PacOrange, Cy3, Cy5 |
iFluor | 350, 405, 430, 450, 488, 514, 532, 546, 555, 560, 568, 594, 610, 633, 647, 660, 670, 680, 700, 710, 750, 790, 800, 810, 820, 840, 860, A7 |
mFluor | UV375, UV460, Violet 450, Violet 500, Violet 510, Violet 540, Blue 570, Green 620, Red 700, Red 780 |
For additional information about custom conjugations, please consult our services page here.
Page updated on September 9, 2025